Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
34.8M
-
Shares change
-
+63.1K
-
Total reported value, excl. options
-
$265M
-
Value change
-
+$480K
-
Put/Call ratio
-
0.54
-
Number of buys
-
3
-
Price
-
$7.60
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2013
81 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q4 2013.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.8M shares
of 210M outstanding shares and own 16.6% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (6.7M shares), WELLINGTON MANAGEMENT CO LLP (4.79M shares), RA CAPITAL MANAGEMENT, LLC (4.35M shares), FMR LLC (2.6M shares), D. E. Shaw & Co., Inc. (2.44M shares), VHCP Management, LLC (1.75M shares), VANGUARD GROUP INC (1.74M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.16M shares), BlackRock Institutional Trust Company, N.A. (1.13M shares), and DEERFIELD MANAGEMENT CO (869K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.